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ABSTRACT
The article emphasizes the anti-inflammatory effects of herbal extracts on different experimental models that are repeatedly used to test the in vivo 
anti-inflammatory activity of herbal components. Edema, granuloma and arthritis models are used to test the anti-inflammatory activity of plant 
extracts whereas formalin or acetic acid-induced writhing test and hot plate methods are the most repeatedly used to evaluate anti-nociceptive 
potentials of the herbal extracts. Although adjuvant-induced and collagen-induced arthritis models are also quite efficient, they have been used 
seldom to evaluate anti-inflammatory tendencies of the herbs. Here, we suggest a double positive reference model using both steroid and nonsteroidal 
anti-inflammatory drugs at the same time, instead of using only one of them either.
Keywords: Anti-inflammatory, Herbal extracts, Experimental models, Carrageenan.
INTRODUCTION
Inflammation is the response of the living system to cell injury. It is a 
protective mechanism that helps the body to identify and neutralize 
the noxious stimuli such as bacterial pathogens, toxic chemicals, 
and cancerous cells by increasing the blood flow to the area of tissue 
injury. Inflammation is also a great hazard to the patient. It increases 
the ailment and sufferings of the patient due to pain and morbidity. 
Arachidonic acid, cyclooxygenase, and lipoxygenase-mediated activation 
of local inflammatory mediators such as leukotrienes, prostaglandins, 
prostacyclin, thromboxane A2, and platelet-activating factor play a key 
role in tissue destruction and pain associated with inflammation [1,2]. 
Inflammation often results in puss formation that may hinder the 
absorption of different antibiotics into the affected tissue that leads 
to the aggravation of tissue destruction. Hence, it becomes mandatory 
to administer anti-inflammatory drugs to cure a number of disorders 
such as infectious diseases in combination with antibiotics. Although 
a number of different synthetic and semi-synthetic drugs are in use 
today to combat inflammation, there has always been a thirst to 
search for the natural anti-inflammatory constituents from various 
plants and spices. The medicinal importance of spices [63] and herbs 
is known since ancient times. Most of the today’s allopathic medicines 
are either consisted of herbal extract, or these are the semi-synthetic 
derivatives of herbal products. Since prehistoric times, herbs are famous 
in traditional medicine for their anti-inflammatory, antinociceptive, and 
immunomodulatory activities. Many researchers have directly tested 
the inhibitory effect of different herbal extracts on the production of 
inflammatory mediators using different cell culture techniques [3-5]. 
Such in vitro studies are helpful in developing an understanding of 
the mechanism of anti-inflammatory activity of herbal compounds; 
however, most of such in vitro studies are secondary to a preliminary in 
vivo evaluation of anti-inflammatory properties of plant extracts [6-9]. 
Different researchers have used different experimental models to 
evaluate the anti-inflammatory activity of herbal extracts. Here, we have 
summarized all those in vivo and in vitro methods that are repeatedly 
being used to evaluate the anti-inflammatory activity of herbs and spices.
IN VIVO SCREENING MODELS
In these in vivo screening methods, the potency of anti-inflammatory 
agents is measured by inducing the inflammation in experimental 
animals such as rats, mice, monkeys, and dogs of either sex can be used. 
The inflammation inducers used commonly are carrageenan, mustard, 
dextran, egg-white, compound 48/80, Yeast, Zymosan-LOX, Serotonin, 
histamine, Kaolin, Substance –p, nystatin, glass powder, cobra venom, 
etc. Before starting any in vivo assay, it is important to study the oral acute 
toxicity study for the selection of test dose. In this, maximum tolerated 
and minimum toxic dose are calculated by injecting the test dose at an 
interval of 2 h in 10, 50, 100, 200,…, 2000 mg/kg patterns [10].
Experimental animals
Some researchers have used big ear albino rabbits [10] most of them have 
preferred using mice and rats to test the anti-inflammatory activities of 
herbal extracts. Different types of mice and rats that are frequently used 
to test the anti-inflammatory effect of herbs include ICR mice [6-8,11-13], 
Sprague Dawley (SD) rats [6,11,13-16], ddY mice [2], BALB/c [18] and its 
sub-strain BALB/cj mice [12], C57BL/6 commonly called as black 6 [4], 
Swiss albino mice [19,20], albino rats [21], and Wistar rats [20,22]. The 
animals are allowed free access to food (Laboratory chow) and tap water 
ad libitum. They are accommodated in a specific pathogen-free animal 
facility (in a laminar air flow room), at a suitable temperature of 22±1°C 
and 40–60% RH in a light/dark cycle of 12 h [11,12] for 2 weeks or more.
Types of screening methods
Based on the symptoms observed during inflammation in vivo screening 
methods for anti-inflammatory drugs are characterized into three 
phases as below [42].
Acute or transient phase
Vasodilation and increased capillary permeability are perceived.
Sub-acute phase
In this, infiltration of leukocytes and phagocytes in blood is observed.
Chronic inflammatory phase
Here, granuloma that is tissue degeneration and fibrosis was observed.
IN VIVO SCREENING MODELS
Carrageenan-induced paw edema in rats [1,23,27,28,42,61,62]
A solution of carrageenan in saline is injected subcutaneously in rats 
induces an acute swelling that becomes maximal after 3–5 h of the 
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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injection and subsides by 24 h [60]. The inflammation produced in 
this model can be used to measure the production of inflammatory 
mediators at sites of inflammation, the anti-inflammatory properties of 
nonsteroidal anti-inflammatory drugs, the efficacy of alleged analgesic 
compounds to reverse cutaneous sensitivity. This method produces and 
measures carrageenan-induced inflammation in the footpad, which can 







Carrageenan: 0.5–2.0% (w/v) carrageenan solution.
Pour 500 ml of sterile 0.9% saline into a 1 L beaker and give a stir. Slowly 
add 2.5 g (0.5%)–10.0 g (2.0%) carrageenan powder to the beaker. Heat 
the solution to 90°C with continuous stirring; do not allow the solution 
to boil. Heating the mixture helps to dissolve the carrageenan; it takes 
<1 h to dissolve all of the powder. Pour the solution into a clean and 
sterile 1 L glass bottle. After cooling the solution at room temperature 
equipped into sterile, 100 ml capped bottles. This solution is stable for 
at least 1 week when stored at 4°C [44].
Methodology
Take male or female SD rats with a body weight between 150 and 170 g. 
The animals are starved overnight. The animal should be grouped; this 
grouping is based on test compounds. After 30 minutes, test the rats by 
subcutaneous injection of 0.05 ml of 1% solution of carrageenan into 
the plantar side of the left hind paw. The paw is marked with ink at the 
level of the lateral malleolus and immersed in the mercury up to the 
mark [42].
Evaluation
Measure the paw volume using plethysmometer or micrometer at 3 
and 6 h, eventually at 24 h immediately after the injection. Calculate 
the increase in paw volume at 3 and 6 h. The percentage increase in 
paw volume was measured by comparing the difference of the average 
values between treated group animals and control group animals is 
calculated at each interval of time. A dose-response curve is run for the 
active drugs to determine the ED50 values. The treated group animals 
show much less edema than control group animal [42].
Calculations:
% edema produced by carrageenan alone=A–B/B×100=X %
% edema produced by carrageenan after treating with drug=C–D/
D×100=Y %
% reduction of edema by drug = X– = --- % [45].
Croton oil-induced ear edema
In this method both rats and mice are used, usually male rats (SD) of 
80–60 g are selected, whereas male Swiss mice weighing between 18 
and 22 g are selected. They are grouped according to the body weight. 
In this approach, a total of 15mul containing an acetonic solution of 
75	μg	of	croton	oil	is	applied	to	the	inner	surface	of	the	right	ear	of	each	
mouse. The animals are previously, anesthetized with diethyl ether at a 
rate of 0.02 ml in rats and 0.01 ml in mice [1,34,44].
Methodology
By keeping the left ear untreated, the control group receives the irritant 
solution; indomethacin is a standard or reference. Changing dose 
levels of test drug are applied to the inner surface of the right ear of 
mouse that induces inflammation. When the test and standard drugs 
are given, the animals are sacrifice by cervical dislocation. Both treated, 
and untreated ears are removed, and a plug of about 8 mm diameter is 
removed from each of the ear. The difference in the weight between two 
plugs is taken as the measure of edematous response [44].
Evaluation
This methodology is mainly used to detect the anti-inflammatory 
activity of steroidal compounds. The percentage anti-inflammatory 
activity is calculated by Sindhu et al. [44],
% anti-inflammatory activity = (wt. of the treated ear - wt. of untreated 
ear/wt. of control ear) *100
Oxazolone-induced ear edema
This model allows the quantitative estimation of the topical and 
systemic anti-inflammatory activity of the compound following topical 
administration.
Methodology
The mice are used as an experimental animal in this model, and they 
are divided as 12 into each group. Inject 10 ml of 0.5% of oxazolone in 
acetone into the right ear and the same was given repetitively 3 times per 
week, to the sensitized right ear. Acetone alone is given in non-sensitized 
animals. The mice are again injected with the solution of oxazolone 
0.01 ml of 2% inside the right ear, in which test or standard solutions 
are resolved. Animals in a group of 10 to 15 are treated with irritant 
alone or with the test compound solution. The left ear remains untreated 
and actual inflammation occurs after 24 h. Animals are sacrificed 
under anesthesia, at this time, and a disc of 8mm diameter is punched 
from both the sides. Allow the disc to dry and weigh on a balance. The 
difference in weight is an indicator of inflammatory edema [44].
Evaluation
Calculate average values of the increase in the weight for each treated 
group and compare statistically with the control group.
UV-B erythema in guinea pigs
Methodology
This method includes that the use of Albino guinea pigs of both the sexes 
weighing about 350 g is used. For the treatment and control group, four 
animals are used. Shave the animals 18 h before the experiment, on 
both the sides and on the back, chemically by means of a depilatory 
cream or with a suspension of barium chloride. The next day dissolves 
the test compound in the vehicle, and half of it is administered to the 
animal by gavage, 30 min before the UV exposure. The control animals 
are treated only with the vehicle. The guinea pigs are placed in a leather 
shackle with a hole of 1.5 cm×2.5 cm size pierced in it, allowing the 
UV radiation to reach only this area. Administer the remaining half of 
the test compound during this time. Normally, the erythema is recorded 
after 2 and 4 h of exposure [44].
Evaluation
Evaluate the degree of erythema by the double-blind method. The 
following scores are given:
0 - No erythema
1 - Weak erythema
2 - Strong erythema
4 - Very strong erythema
Animals with a score of 0 or 1 are said to be protected. The scoring after 




The animal used in the pleurisy test is the mouse. Inject a single 
dose of 0.1 ml carrageenan intravenously. After 4 h kill the animal 
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with an overdose of ether and wash the pleural cavity with 1.0 ml 
of sterile phosphate-buffered saline (PBS), containing heparin 
(20 IU per ml). Collect the samples of the pleural lavage and determine 
the exudation, nitric oxide (NO) levels, adenosine deaminase activities, 
myeloperoxidase, and total differential leukocyte counts. Perform total 
leukocyte counts in a Neubauer’s Chamber. Analyze the serum level of 
the C-reactive protein. In another set of experiment treat animals with 
a solution of Evans blue dye (25 mg/kg, i.v.), 30 min before carrageenan 
so as to evaluate the degree of exudation in the pleural space [43].
Estimate the amount of dye at 600 nm by colorimetry using an ELISA 
Plate Reader, by interpolation from a standard curve of Evans Blue Dye 
in the range of 0.01–50 µg/ml.
Evaluation
Average and compare the values of each experimental group with that 
of control. Calculate ED50 values using various doses.
Granuloma air pouch techniques
Methodology
The animals used in this method are male or female SD rats with a 
body weight between 150 and 200 g. Take 10 animals for control 
and test groups. Shave and disinfect the back of the animals. Make a 
pneumoderma, by injecting 20 ml of air under ether anesthesia in the 
middle of the dorsal skin with a very thin needle, which results in an 
oval air pouch. Inject 0.5 ml of a 1% solution of croton oil in sesame oil, 
avoiding any leakage of air. Remove the air pouch after 48 h [44].
•	 Inject	the	test	compound	directly	into	the	air	sac	at	the	same	time	
as the irritant.
•	 Sacrifice	the	animals	on	the	4th or 5th day under anesthesia.
•	 Open	the	pouch	and	collect	the	exudate	in	glass	cylinders.
•	 Evaluate	total	number	of	leukocytes	migrate	into	the	pouch	are	after	
staining with erythrosine B.
Evaluation
Calculate the average value of the exudates of the control and the test 
groups. Compare it by statistical means.
Increased vascular permeability by arthus reaction
Methodology
In this method ALBINO Wistar rats are used, 4 rats in each group. 
Administer distilled water, 1% w/v 1 ml/100 g by oral route to control 
group and the test compound to another group by oral route and to the 
standard group diclofenac 10 ml/kg by intraperitoneal route. 1 h after 
the administration, inject rats with 0.25 ml of 0.6% v/v solution of acetic 
acid intraperitoneally [50]. Immediately inject 10 ml/kg of 10% w/v of 
Evans blue intravenously through the tail vein. Anesthetize the animals 
after 30 min, with ether anesthesia and sacrifice. Cut the abdomen, 
open and expose viscera. Hold the animals by a flap of abdominal wall 
over Petri dish. Collect the peritoneal fluid (exudates), filter and make 
up the volume up to 10 ml using normal saline solution and centrifuged 
at 3000 rpm for 15 min. Measure the absorbance (A) of the supernatant 
at 590 nm by means of spectrophotometer [56].
Evaluation
The decrease in the concentration of dye with respect to absorbance 
indicates the reduction in permeability.
Adjuvant arthritis [29]
Freund’s complete adjuvant-induced arthritis in rat model is the 
most widely used experimental model for arthritis with clinical and 
laboratory features that closely mimic the clinical features of human 
rheumatoid disorder [1,32,33,49]. This model is sensitive to anti-
inflammatory and immunosuppressant medicines and considers being 
appropriate for the study of pathophysiological and pharmacological 
control of inflammation progression as well as for the evaluation of the 
potential of analgesic drugs.
Methodology
On day zero, inject animals with 0.1 ml of complete Freund’s adjuvant 
(FA) into the subplantar region of the left hind paw. This consist of 
6 mg of Mycobacterium butyricum suspended in heavy paraffin oil by 
grinding with mortar and pestle to give a concentration of 6 mg/ml. 
Administer dosing with the test and standard compounds on the same 
day and continue for 12 days as per the following schedule. From 
day 13th to 21st, do not dose the animals with the test or the standard 
compound. Evaluate by comparing certain parameters between the 
control and treatment.
Papaya latex-induced arthritis
Papaya latex-induced arthritis model of experimental rheumatoid 
arthritis has been developed to test the anti-inflammatory effect of 
slow reaction antirheumatic drugs. Papaya latex-induced inflammation 
is supposed to be mediated through prostaglandins [44,46,47].
Methodology
Prepare 0.25% solution of papaya latex to take 0.1 ml 
(prepared in 0.05 M sodium acetate buffer and pH 4.5 with 0.01% 
thymol) and inject into the rat back foot (hind paw). The peak effect 
occurs at 3 h and continues for more than 5 h. The method is sensitive 
for evaluating nonsteroidal anti-inflammatory drugs (NSAIDs) such as 
aspirin, ibuprofen, and nonsteroidal anti-inflammatory drugs [46,47].
Candida albicans induced arthritis
Methodology
Repeated injection with Streptococcus pyogenes cell wall (SCW) 
fragments into the knee joint of C57Bl/6 mice produces chronic 
SCW arthritis alone or in combination with the yeast of C. albicans 
or Zymosan, A. Perform the cytokine levels, mRNA expression and 
histopathological analysis of the joints during the chronic phase of 
arthritis. Investigate the phenotype of the interleukin (IL)-17 producing 
T-cells, isolate and analyze synovial cells by flow cytometry [45].
Arachidonic acid-induced ear edema in mice
Materials
Obtain arachidonic acid, fatty acids, eicosanoids, and histamine (flee 
base). Dissolve the compounds in a 1:1 (v/v) mixture of tetrahydrofuran 
and methanol (HPLC grade, Rathbun). CD1 male mice (weighing 20–25 g) 
and Tuck Wistar male rats (weighing 120–140 g) are used [57,53,54].
Methodology
Apply 2 mg arachidonic acid in 10~1 tetrahydrofuran:methanol to the 
inner surface of each ear. Use various amounts of arachidonic acid in 
ethanol for initial dose-dependency studies. Compounds tested for 
their inhibitory capacity are normally incorporated in the arachidonic 
acid solution and applied only to the left ear. Give the only solvent to 
the control animals on each ear. Kill the animals after 1 h by cervical 
dislocation and cutoff both ears at the hairline and weigh. Assess the 
swelling induced by arachidonic acid as an increase in the weight of the 
right ears over that of the right ears of solvent-treated control animals, 
as an amount of the weight of solvent-treated right ears. The swelling 
induced in the same animals in the presence of test compound was 
likewise the increase in the weight of the left ears over that of the left 
ears of the control animals expressed as a proportion of the weight of 
solvent-treated left ears [52-54].
This value is expressed as percentage of the full (right ear) swelling, 
and hence a percentage inhibition by the test compound is calculated:




x = average weight of the left experimental ears
y = average weight of the left control ears
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a = average weight of the right experimental ears
b = average weight of the right control ears
This method reduces the contribution of inter-animal differences in 
responsiveness to the inflammatory stimuli and also compensates for 
any consistent bias in cutting off left and right ears. The significance 
of the inhibition is calculated using a paired t-test of the two values of 
proportional weight increases. One group of mice is given compound 
48/80 (200 µl of a 0.625 mg/ml solution in sterile saline and equivalent 
to 5 mg compound/kg body weight) subcutaneously 24 h before the 
application of arachidonic acid to the ear [52-54].
Cotton wool edema
Methodology
In this method, male rats weighing about 180–200 g are used. 
Administer the test drugs orally once on a dosage regimen for 7 days 
and vehicle to the control group. Implant two sterilized pellets of cotton 
wool subcutaneously, one on each side of the abdomen of the rat, under 
the ether anesthesia and sterile procedure. Sacrifice the rats on the 
8th day, dissect out the implanted pellet and record the wet weight. 
Dissect out thymuses too. Dry both of these at 60°C for 18 h and record 
the dry weight [23,48,49].
Evaluation
Calculate the weight of transudate and the granuloma as well as the 




In this technique, select a glass rod with a diameter of 6 mm and 
40 mm length. Select male SD rats with an initial weight of 130 g. 
Anesthetize these rats with ether. Shave and disinfect their back 
skins. Forma subcutaneous tunnel in the cranial direction with closed 
blunted forceps by an incision in the caudal region. Introduce the 
glass rod into this tunnel which lies on the back of the animal. Close 
the incision wound using sutures. Keep the animals in separate cages; 
the rods remain in situ for 20 or 40 days. Sacrifice the animals at the 
end, under CO2 anesthesia. The glass rod is prepared with adjacent 
connective tissue which forms a tube around the glass rod. Record wet 
weight of the granuloma tissue, finally dry it and record the dry weight 
also [44,50,51].
Evaluation




Prepare the sponges for implantation from polyvinyl foam sheets with a 
thickness of 5 mm discs and stamped out to a standard size and weight 
(10.0±0.02 mg) using a 13 mm cork tool. Soak the sponges in 75%v/v 
ethanol for 30 min, and then heat at 80°C for 2 h. Before implantation 
in the animal, soak the sponges in sterile 0.9% saline which may 
contain either drugs antigens or irritants suspended in it. Implant the 
sponges in female Wistar rats weighing about 150–200 g under ether 
anesthesia. Make a 20 mm dorsal incision and separate the dermis 
from the underlying muscle layer by insertion of blunted forceps to 
form separate cavities into which the sponges can be inserted. One can 
implant up to 8 sponges per rat. Close the insertion with Michael clips 
and maintain the animals at a constant temperature of 24°C [51].
Evaluation
For the estimation of fluid phase of sponge exudates, for example, protein 
content enzyme levels and biological mediators such as prostaglandins 
as well as for leukocyte migration, remove sponges after 9 h.
Dextran sulfate sodium-induced colitis in mice
This is a new experimental model of colonic inflammation introduced 
by Okayasu et al. [1]. In this model an oral administration of sodium 
salt of a sulfated polysaccharide, dextran sulfate sodium (DSS), is used 
to induce colitis in the mouse, as well as in other species such as the 
hamster [2,3] and the rat [4,5]. Appearance of the DSS-induced animal 
colitis is dependent on the molecular weight and sulfation of the DSS, 
and the dosage and duration of the DSS administration [1,3,6-9].
Animals
Use specific pathogen-free 6–8-week-old female mice. The mice used 
are conventional Balb/c and barrier born nu/nu CD-1 (BR) athymic 
nude mice [25]. Keep the Balb/c mice in standard laboratory conditions 
with free access to animal chow. By keeping the nu/nu CD-1 animals 
in disposable cages with filter tops. Radiation-sterilize bedding 
and autoclave animal chow (R34) for use and keep the animal room 
and facilities aseptic by spraying them with an aqueous solution of 
Benzalkonium chloride.
Induction of colitis
Induce colon inflammation by the administration of DSS in the drinking 
water. Dissolve DSS with Mw 40–44 kDa and a sulfur content of 15.4–
17.0% in ultra-pure water at concentrations of 2.5% and 5.0% with a 
final pH of 8.5. Assess the characteristics of the DSS and its stability in 
solution [7]. Expose the animals to the different DSS solutions ad libitum. 
Test the water and DSS for bacterial endotoxin contamination.
Inhibition of inflammatory granulation
This method is used to study the repair phase characterized by fibroblast 
proliferation and blood vessel formation. Suppression of granulation 
tissue parallels with anti-inflammatory activity is measured [56].
FA arthritis
This is the immunologically mediated model of chronic inflammation. It 
is a delayed hypersensitivity response to mycobacterial Ag. Induction of 
arthritis is done by subplantar injection of Freund’s complete adjuvant 
or mycobacteria suspended in oil [56].
Day 1 Day 4–5 Day 7
 
Local reaction peak systemic disease
Parameters: Foot thickness, wt., grip strength, and deformity are 
measured.
Evaluation of chronically administered drug against inflammation
Drugs effective: Steroids, immunosuppressants, gold, and d-penicillamine.
Guinea pig model of giant papillary conjunctivitis
Chronic exposure of contact lenses to foreign bodies leads to GPC. 
Levels of IL-3, IL-4, IL5, Ig G, Ig E, and Ig M are increased in Tears [56].
Procedure
Insert a sterile needle directly into conjunctiva of the unsensitised 
animal. This pricking results in a high number of neutrophil infiltration.
Xylene-induced ear edema in mice
The acute inflammatory activity of drugs is evaluated using xylene-
induced ear edema in mice as previously described [58,59]. Divide 
the mice randomly into the following five treatment groups of eight 
animals each: Vehicle control (distilled water, 20 mL/kg, p.o.), ASA 
positive control (100 mg/kg, p.o.), and three doses of drug (0.8, 2.4, 
and 7.2 g/kg, p.o.). Administer these treatments orally for 6 consecutive 
days.	On	day	7	 at	 1	h	 after	 oral	 administration,	 apply	30	μl	 of	 xylene	
on both the surfaces of the right ear to induce edema. The left ear 
served as a control. Sacrifice the mice 30 min after xylene treatment by 
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performing cervical dislocation. Remove the right and left ears of the 
mice with 8 mm diameter cork borer and weigh the ears. Measure the 
edema weight difference between the right and left ears of the same 
animal. Compare the percentage of inhibition with the control group and 
calculate using the following formula: %Inhibition=[(Weight of edema 
(control)−Weight	of	edema	(test)]/Weight	of	edema	(control)×100	[40].
Monosodium urate crystal-induced arthritis
The unmetabolized product of purine gets deposited as uric acid 
in the synovial joint which induces activation of kin in leukotriene 
B4, accumulation of neutrophil granulocytes characterized by an 
intermittent attack of Acute Arthritis or Gout. On this, the drugs are 
injected intradermally at the knee joint to produce arthritis. By Injecting 
20 mg sodium urate crystal suspensions in their own knee joint. They 
experienced severe pain and prostration which resembled an acute 
gouty attack [49].
Procedure
Induce inflammation by intradermal injection of 0.2 ml (4 mg) of 
endotoxin-free monosodium urate crystal suspension into the right foot 
pad. Day considered as day 0–3. Start treatment with standard and test 
from day 0 before half hour of MSU and continue for 3 days.
Preparation of monosodium urate crystals
Dissolve about 4 g of uric acid in 800 ml water and heat with NaOH 
(9 ml/0.5 N), adjust pH to 8.9 at 60°C; cool overnight in a cold room; 
wash and dry. Recover needle-like crystals and suspend in sterile saline 
(20 mg/ml).
Grip strength of arthritic animals
In this method, the inducer of arthritis is silver nitrate which is 
injected in the tibiotarsal joint of rats or by means of intra-articular 
talc injections in pigeons. This impairs the locomotor activity with 
inflamed paws. Effective drugs are NSAIDs, steroids, DMARDs, and anti-
histamines [56].
Inhibition of NO production induced by tumor necrosis factor-
alpha (TNF-α) in mouse macrophages
Animals
Mice C57BL/6.
Infection and treatment with mAb against TNF-α
Subcutaneously infect resistant C57BL/6 mice in the footpad with 
2×106 promastigote forms in stationary phase. Inject the animals 
i.p.	with	 500 μg	 anti-TNF-α	mAb	 (XT22.11),	 2	 h	 before	 the	 infection,	




tolerant to IgG [21,41].
Determination of disease progression
Monitor the development of lesions by measuring the increase in 
footpad thickness as compared to the uninfected one. Determine 
the number of parasites in the lesion by a modified limiting dilution 
analysis applying Poisson statistics and the χ2-minimization method, 
using a computer program (ELIDA) [55].
Determination of serum nitrate concentration
The nitrate (NO3–) presents in the serum samples are obtained from 
infected	 and	 TNF-α	 mAb-treated	 animals	 and	 are	 reduced	 to	 nitrite	
with nitrate reductase and determine the nitrate concentration by the 
Griess method [26,56].
Inducible nitric oxide synthase (iNOS) activity assay [39]
Collect the popliteal lymph nodes from C57BL/6 mice treated with 
anti-TNF-α,	nIgG,	or	saline	at	the	2nd, 6th, and 12th weeks after infection 
with L. major, and determine iNOS activity by measuring the formation 
of 14C citrulline as described [57]. iNOS activity is expressed as pmol 
citrulline/mg protein/h.
Immunolocalization of iNOS in macrophages and neutrophils on 
footpad lesions
Insert the footpad tissues and draining lymph nodes in OCT compound, 
freeze	and	store	at	–70°C.	Place	 the	 tissue	sections	of	5 μm	thick,	on	
L-poly-lysine-coated slides fixed in acetone, and block nonspecific 
protein	 binding	 with	 goat	 serum	 (diluted	 1:200	 in	 PBS)	 for	 45 min.	
Incubate the slides with primary rabbit anti-mouse iNOS antibody (Santa 
Cruz Biotechnology, CA; diluted 1:200 in PBS plus 1% BSA) overnight. 
The reaction product is detected with avidin-biotin-peroxidase 
complex (Vector Laboratories, Burlingame, CA), and develop the color 
of the reaction with diaminobenzidine tetrahydrochloride (DAB; Sigma, 
St. Louis, MO). Counterstain the slides with Mayer’s hematoxylin. Score 
the observed intensity of the reaction on the slides as absent, discrete, 
moderate, or intense [55,56].
IN VITRO SCREENING MODELS
COX assay
COX-1
Add 10 ml of the sample solution to 19 ml of 0.1M of L-adrenaline, 
dihydrogen tartrate, and 10 mM of hematin. After adding 0–2 units 
of COX-1 pre-incubate for 5 min by adding 10 mL of 10% formic 
acid. Measure the PGE2 concentration with a PGE2 enzyme immune 
assay [41].
COX-2
Prepare assay mixture with 100 mm rod phosphate, 1 mm of hematin 
gelation, 2.5 mL of the compound in DMSO. It is to be pre-incubated for 
15 min at 22°C and add the 20 ml of 1 mM arachidonic acid solution and 1 
mM Thermal power management device (TPMD) in assay buffer. Measure 
the absorbance at 400 nm over the fast 36 s and calculate percentage 
inhibition. Observe the enzyme inhibition of TPMD in the absence of COX-
2 and subtract from activity in the presence of COX-2 [35,41].
Mast cell degranulation
Inject heparinized Tyrode solution into the peritoneal cavity of 
exsanguinated rat (SD) after the abdominal massage, harvest and 
separate the cells in peritoneal fluid through 38% Bovine Serum 
Albumin. Wash the cells and suspend in Tyrode solution with 0.1% 
BSA. Pre-incubate the cell suspension with test drugs at 37°C for 
3 min,15 mins after addition of compound 48/80 (standard compound 
for mast cell degranulation), glucuronidase (1mM Phenolphthalein-D-
glucuronide in 0.1 M acetic acid buffer, pH 4.5 is used as a substrate, and 
monitor absorbance at 550 nm after alkalization), and histamine (0.2% 
o-phthalaldehyde condensation in pH 12.5 fluorescence is monitored 
at 350/450 nm after acidification) in the supernatant is determined. 
Measure the total content after treatment of the cell suspension with 
Triton X-100. Determine the percentage release as the index of anti-
inflammatory activity [41].
Platelet-neutrophils adhesion
Thrombin-activated human platelets are incubated with the drug at 
20°C for 10 min and mixed with neutrophils at a ratio of 10:1. Neutrophil 
with two or more (number positives) and one or no adherent platelets 
(number negatives) is counted as an index of activity. The test drug 
blocks the adhesion with respect to controls [41].
Cell viability
Cell viability is evaluated using a 3-(4,5-dimethyl-thiazole-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT)-based colorimetric assay 
(Diaz-Lanza et al., 2001). Pipette cells (8×105) diluted with Dulbecco’s 
modified Eagle’s medium with 10% heat-inactivated fetal calf serum 
(FCS) into 96-well microtiter plates and were incubated overnight at 
37°C and 5% CO2. They were exposed to various concentrations of 
samples for 3h under the same conditions of incubation. MTT solution 
dissolved in phosphate-buffered saline was added to the wells at 
34
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1mg/ml final concentration. After carefully aspirating the medium, 
100 µL of DMSO was added for the dissolution of formazan crystals. The 
absorbances of all wells were then read at 520 nm using a microplate 
reader. The values of the maximum non-toxic concentration obtained 
were used in PGE2 and LTB4 determination [41].
Apart from these methods following methods are used for the screening 
of anti-inflammatory drugs:
 Formalin induced paw oedema [24,36]
 Streptococcal cell wall (SCW) arthritis [30]
 Collagen-induced arthritis (CIA) mouse model [31]
 Cell-based reporter gene assay
 FMLP-induced O2 generation by poly morpho nuclear cells (PMNs).
 FMLP-induced adhesion of PMN of HUVEC
 3-H bradykinin receptor binding [49]
 3-H Substance P receptor binding
 Assay of PMNL chemotaxis
 PMNL aggregation constitutive and inducible cellular arachidonic 
acid metabolism
 Formation of leukotriene B4 in human white blood cells
 Formation of lipoxygenase products from 14C-arachidonic acid in 
human PMN
 Formation of eicosanoids from 14C-arachidonic acid in human platelets
	 Bovine	serum-induced	inflammation	[37]
 HRBC membrane stabilization method.
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